Pankaj Mohan - 27 Oct 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role: Chairman, President and CEO, Director
Signature: /s/ John Harry Cross III, power of attorney
Issuer symbol: SONN
Transactions as of: 27 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Oct 2023, 20:00:08 UTC
Previous filing: 15 May 2023
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SONN	Common Stock	Purchase		+34,375	+137%		59,526	27 Oct 2023	Direct	F1, F2, F3
holding	SONN	Common Stock						25	27 Oct 2023	By Child	F4
holding	SONN	Common Stock						3,021	27 Oct 2023	By Mohan Family Office	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SONN	Warrant to Purchase Common Stock	Purchase		+68,750			68,750	27 Oct 2023	Common Stock	68,750	$1.60	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person purchased 34,375 shares of common stock and 68,750 warrants to purchase 68,750 shares of common stock pursuant to an underwritten public offering by the Issuer at $1.60 per share and accompanying two warrants. The offering closed on October 27, 2023.
F2	Includes unvested restricted stock units.
F3	All amounts reflect the 1:22 reverse stock split effective as of August 31, 2023.
F4	Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.